The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society clinical practice guideline
Open accessAbstract
OBJECTIVE: To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes. PARTICIPANTS: The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology co-sponsored this guideline. EVIDENCE: The Task Force developed this evidence-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned one systematic review and used the best available evidence from other published systematic reviews and individual studies. CONSENSUS PROCESS: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. CONCLUSIONS: Continuous subcutaneous insulin infusion and continuous glucose monitoring have an important role in the treatment of diabetes. Data from randomized controlled trials are limited on the use of medical devices, but existing studies support the use of diabetes technology for a wide variety of indications. This guideline presents a review of the literature and practice recommendations for appropriate device use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Intensive insulin management education programs that include nutrition therapy have been shown to improve A1C (9,264,268,271 -273) and quality of life (9,274).”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [272]
Experimental — accuracy not yet measuredIn the citing paper
“There is also evidence that insulin pump therapy may reduce DKA risk (182,186) and diabetes complications, particularly retinopathy and peripheral neuropathy in youth, compared with MDI (169).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [169]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Part of this paper’s reference list could not be split into single entries.
1 retracted
Grant, P. S., Dorota Dworakowska, B., DeZoysa, N., & Barnes, D. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.06.003 · Cited by 17
Retracted(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Self-citationNathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Amiel, S. A., Beveridge, S., Bradley, C., Gianfrancesco, C., Heller, S. R., James, P., McKeown, N., Newton, D. F., Newton, L. D., Oliver, L., et al. (2002) · Deakin Research Online (Deakin University) · Cited by 723
Research works printed but not linked: 2
- American Diabetes Association. 7. Approaches to glycemic treat- ment. Diabetes Care. 2015;38:S41-S48.
- Golden SH, Brown T, Yeh HC, et al. AHRQ Comparative Effec- tiveness Reviews. Methods for Insulin Delivery and Glucose Mon- itoring: Comparative Effectiveness Review No. 57. Rockville, MD: Agency for Healthcare Research and Quality; 2012.
Cited by
Sorted by citations
Items 201–248 of 248
Investigating Ectopic Sites for Islet Transplantation
Salama, B. F. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-md1t-t023
Inpatient Insulin Pump Management
Vamvini, M. T., & Toschi, E. (2020) · Springer eBooks · doi:10.1007/978-3-030-38976-5_27
Chillarón, J. J., Climent, E., Llauradó, G., Ballesta, S., & Roux, J. A. F. (2020) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2019.12.005
Quality study of insulin formulations
Pajaziti, B., Gáspár, A., Andrási, M., Nebija, D., & Петковска, Р. (2020) · Macedonian Pharmaceutical Bulletin · doi:10.33320/maced.pharm.bull.2020.66.03.075
Barrera, F. J., Raygoza-Cortez, K., García-Leal, M., Brito, J. P., Ospina, N. S., & Rodríguez‐Gutiérrez, R. (2021) · Endocrine · doi:10.1007/s12020-020-02592-y · Cited by 1
Placement of insulin pump by telemedicine
Foglia, A. (2020) · The Journal of AMD · doi:10.36171/jamd20.23.4.6
Grassi, G. (2020) · The Journal of AMD · doi:10.36171/jamd20.23.1.10
Cardiometabolic Risk Reduction: A Review of Clinical Guidelines and the Role of SGLT-2 Inhibitors
Reid (2021) · The Journal of Family Practice · doi:10.12788/jfp.0216
Use of SGLT-2 Inhibitors in Patients with Chronic Kidney Disease
Mottl (2021) · The Journal of Family Practice · doi:10.12788/jfp.0225
Improving Shingles Vaccination Rates in Family Medicine
Luther (2021) · The Journal of Family Practice · doi:10.12788/jfp.0218
The Challenge: Finding the Most Appropriate Statin and Dose for Each Patient
Lillo (2021) · The Journal of Family Practice · doi:10.12788/jfp.0224
Lamos, E. M., Younk, L. M., & Davis, S. N. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch31
Botero, J. F., Vásquez, L. M., Blanco, V. M., Cuesta, D., Rincón, A. R., Bedoya, J., & Palacio, A. (2021) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2021.12.002
Perfilando la tecnología en diabetes
Gómez, N. B., Jiménez-Salazar, S., Delgado, M. R., Botero, J. F., & Rincón, A. R. (2024) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.11.1.852
Sharafieh, R., Qiao, Y., Godlewski, I., Czajkowski, C., Wu, R., Hargis, G. R., Kreutzer, D., & Klueh, U. (2024) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2024.100511
Insulin Pump Therapy Advantages and Disadvantages
(2024) · American Diabetes Association eBooks · doi:10.2337/9781580408363.ch01
(2024) · American Diabetes Association eBooks · doi:10.2337/9781580408363.ch05
Pump, Infusion Set, and Insulin Options and Selection
(2024) · American Diabetes Association eBooks · doi:10.2337/9781580408363.ch02
(2021) · American Diabetes Association eBooks · doi:10.2337/9781580407694.ch07
Zadel, A. H., Chiampas, K., Maktaz, K., Keller, J. G., O'Gara, K. W., Vargas, L., Tzortzakis, A., Eimer, M. J., & Szmuilowicz, E. D. (2024) · doi:10.2196/preprints.69061
Impacto del inicio de la monitorización flash de glucosa en pacientes adultos con diabetes tipo 1
Sahagún, R. J. (2024) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/72390
Starting Insulin Pump and Continuous Glucose Monitoring Therapy
Peters, A. L. (2019) · doi:10.2337/9781580406932.part1_ch07
Self-citationPerioperative Continuous Subcutaneous Insulin Infusion Use
Sobel, S. I., Korytkowski, M. T., & Donihi, A. C. (2019) · doi:10.2337/9781580406932.part1_ch13
Clinical pharmacist roles in a virtual continuous glucose monitor initiation service
Wettergreen, S. A., Sobczak, C., Jortberg, B. T., Oser, S. M., Buss, D., Parascando, J. A., Daffron, A., & Oser, T. K. (2025) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.70046
Kaya, A. (2025) · Medical Records · doi:10.37990/medr.1645581
Singh, G., Vamvini, M. T., & Toschi, E. (2025) · Springer eBooks · doi:10.1007/978-3-031-86099-7_27
Eer, A., Hachem, M., Hearn, T., Koye, D. N., Atkinson‐Briggs, S., Jones, J. L., Eades, S., Braat, S., Twigg, S. M., Sinha, A. K., et al. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01607-7
Technological innovations in the treatment of diabetes over the last decade
Sonia, T. A., & Sharma, C. P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30272-5.00011-1
Avari, P., Robinson, C., Leelarathna, L., & Thabit, H. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251381282
Olsen, M. T., Klarskov, C. K., Pedersen-Bjergaard, U., Hansen, K. B., & Kristensen, P. L. (2024) · Figshare · doi:10.6084/m9.figshare.26716423
Olsen, M. T., Klarskov, C. K., Pedersen-Bjergaard, U., Hansen, K. B., & Kristensen, P. L. (2024) · Figshare · doi:10.6084/m9.figshare.26716426
Alruwaili, T. Z., Absher, S. M. T., Alanazi, S. S., El-Malky, A., & Alqahtani, M. M. (2025) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2025.154011
Insulin Pump Therapy in the Hospital
Thompson, B., Boyle, M. E., & Cook, C. B. (2025) · Medical Clinics of North America · doi:10.1016/j.mcna.2025.11.009
Actuator-Aware Evaluation of MPC and Classical Controllers for Automated Insulin Delivery
Iqbal, A., Goswami, P., & Naseem, H. (2026) · Actuators · doi:10.3390/act15010035
Chua, A. Y., & Villa, M. L. (2018) · Philippine Journal of Internal Medicine · doi:10.65564/pjim.e77e273ac5
Ll, Z., Chen, N., Wang, Y., & Pan, T. (2026) · European journal of medical research · doi:10.1186/s40001-026-04125-1
Rehan, K., Rehan, I., Alam, H., Rehman, M. U., & Ullah, R. (2026) · Spectroscopy Letters · doi:10.1080/00387010.2026.2647104
Les cellules MAIT dans le diabète de type 1 chez l'homme
Nel, I. (2019) · theses.fr (ABES) · doi:10.70675/8eaa5bd8z1217z4729z8c2ezb385e0dbc1a9
Why glycemic control remains suboptimal in type 1 diabetes in the era of advanced technologies?
Joubert, M. (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101763
Assisted Devices and Daily Life Adaptations in Diabetes
Das, U., Roy, D., Singh, S., & Mandal, S. (2026) · Springer eBooks · doi:10.1007/978-981-95-8946-3_13
Petersen, J. J., Faltermeier, P., Juul, S., Kamp, C. B., Sillassen, C. D. B., Santos, T. J. D., & Jakobsen, J. C. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-100186
Gallen, G., Alice, R., Alonso-Carril, N., Arbeli, S., Bahon, V., Vanessa, B., Kerstin, E., Verena, S., Audrey, H., Jolley, A., et al. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02718-0
Diabetes Technology in Children
Zhou, Y., & Wheeler, B. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-24854-1_14
The Diabetes Technology Timeline
Sriravindrarajah, A., Forner, P. M., & SNAITH, J. R. (2026) · Springer eBooks · doi:10.1007/978-3-032-24854-1_1
Integration of Artificial Intelligence in Biosensors and Healthcare Applications
Özen, S., Köse, E., & Karakuş, S. (2026) · Biomedical engineering · doi:10.5772/intechopen.1017833
Ameur, A. (2026) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2026.1941126
Olsen, M. T., Spanakis, E. K., Thabit, H., Dhatariya, K., Mustafa, O. G., Avari, P., Lumb, A. N., Dungan, K. M., Philis‐Tsimikas, A., Kulasa, K. M., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06838-8
Self-citation
Metadata
- Authors
- Peters, A. L., Ahmann, A. J., Battelino, T., Evert, A., Hirsch, I. B., Murad, M. H., Winter, W. E., & Wolpert, H.
- Affiliations
- University of Southern California (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-11
- Volume
- 101
- Issue
- 11
- Pages
- 3922-3937
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2518284272
- Cited by
- 250
- References
- 115
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 17 · 2023: 19 · 2022: 23 · 2021: 39 · 2020: 31 · 2019: 32 · 2018: 31 · 2017: 19 · 2016: 2
- FWCI
- 28.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- diabetes technology, insulin pump therapy, continuous glucose monitoring, adults with diabetes, diabetes management, clinical guidelines
- MeSH terms
- Adult, Blood Glucose, Combined Modality Therapy, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diet, Diabetic, Endocrinology, Humans, Hyperglycemia, Hypoglycemia, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, International Agencies, Patient Education as Topic, Societies, Scientific, Exercise, Drug Monitoring, Monitoring, Ambulatory, Evidence-Based Medicine, Consensus, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
